Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands.
Identifieur interne : 000715 ( PubMed/Checkpoint ); précédent : 000714; suivant : 000716Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands.
Auteurs : Laura Christina Wittkampf [Pays-Bas] ; Hugo M. Smeets ; Mirjam J. Knol ; Mirjam I. Geerlings ; Arjan W. Braam ; Niek J. De WitSource :
- Social psychiatry and psychiatric epidemiology [ 1433-9285 ] ; 2010.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Antidépresseurs (usage thérapeutique), Anxiolytiques (usage thérapeutique), Classe sociale (MeSH), Ethnies (statistiques et données numériques), Femelle (MeSH), Groupes de population (statistiques et données numériques), Humains (MeSH), Maroc (ethnologie), Minorités (statistiques et données numériques), Mâle (MeSH), Neuroleptiques (usage thérapeutique), Ordonnances médicamenteuses (statistiques et données numériques), Pays-Bas (ethnologie), Prévalence (MeSH), Psychoanaleptiques (usage thérapeutique), Troubles mentaux (ethnologie), Troubles mentaux (traitement médicamenteux), Troubles mentaux (épidémiologie), Turquie (ethnologie), Utilisation médicament (tendances), Émigrants et immigrants (MeSH).
- MESH :
- ethnologie : Maroc, Pays-Bas, Troubles mentaux, Turquie.
- statistiques et données numériques : Ethnies, Groupes de population, Minorités, Ordonnances médicamenteuses.
- tendances : Utilisation médicament.
- traitement médicamenteux : Troubles mentaux.
- usage thérapeutique : Antidépresseurs, Anxiolytiques, Neuroleptiques, Psychoanaleptiques.
- épidémiologie : Troubles mentaux.
- Adolescent, Adulte, Adulte d'âge moyen, Classe sociale, Femelle, Humains, Mâle, Prévalence, Émigrants et immigrants.
- Wicri :
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Anti-Anxiety Agents (therapeutic use), Antidepressive Agents (therapeutic use), Antipsychotic Agents (therapeutic use), Drug Prescriptions (statistics & numerical data), Drug Utilization (trends), Emigrants and Immigrants (MeSH), Ethnic Groups (statistics & numerical data), Female (MeSH), Humans (MeSH), Male (MeSH), Mental Disorders (drug therapy), Mental Disorders (epidemiology), Mental Disorders (ethnology), Middle Aged (MeSH), Minority Groups (statistics & numerical data), Morocco (ethnology), Netherlands (ethnology), Population Groups (statistics & numerical data), Prevalence (MeSH), Psychotropic Drugs (therapeutic use), Social Class (MeSH), Turkey (ethnology).
- MESH :
- chemical , therapeutic use : Anti-Anxiety Agents, Antidepressive Agents, Antipsychotic Agents, Psychotropic Drugs.
- geographic , ethnology : Morocco, Netherlands, Turkey.
- drug therapy : Mental Disorders.
- epidemiology : Mental Disorders.
- ethnology : Mental Disorders.
- statistics & numerical data : Drug Prescriptions, Ethnic Groups, Minority Groups, Population Groups.
- trends : Drug Utilization.
- Adolescent, Adult, Emigrants and Immigrants, Female, Humans, Male, Middle Aged, Prevalence, Social Class.
Abstract
BACKGROUND
Psychotropic drug use in Europe and the USA has increased in the past 20 years. The rise in mental health-care use instigated a debate about possible differences in prevalence rates between different ethnic groups in the Netherlands, although the exact differences were unknown. The aim of this study was to determine whether these minority groups were more or less likely than the native population to receive psychotropic drugs.
METHODS
A descriptive population study was conducted using the Agis Health Database, containing demographic and health-care consumption data of approximately 1.5 million inhabitants of the Netherlands. Rates of prescriptions of psychotropic drugs from 2001 to 2006 and adjusted odds ratios for psychotropic drug prescriptions among native Dutch, Turkish and Moroccan ethnic groups were calculated. These data were analysed using logistic regression, after being adjusted for age, gender and socioeconomic status.
RESULTS
The mean year prevalence of psychotropic drug prescriptions from 2001 to 2006 was 14.0%. Except for a decrease in anxiolytic drugs, the prescriptions of psychotropic drugs increased from 2001 to 2006. These trends were the same for all of the ethnic groups considered. Among both the Moroccan and Turkish populations, there was a higher risk of antidepressant and antipsychotic drug prescriptions, and a pronounced lower risk of ADHD medication and lithium prescriptions compared to the native population. Among the Turkish population, the risk of anxiolytic drug prescriptions was greater than in the native population.
CONCLUSIONS
Compared to the native population in the Netherlands, first- and second-generation Turkish and Moroccan immigrants had an increased risk of antidepressant and antipsychotic drug prescriptions and a decreased risk of ADHD medication and Lithium prescriptions. Further research is needed to clarify whether patients of different ethnic backgrounds with the same symptoms receive similar diagnosis and adequate treatment.
DOI: 10.1007/s00127-009-0123-4
PubMed: 19701593
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19701593Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands.</title><author><name sortKey="Wittkampf, Laura Christina" sort="Wittkampf, Laura Christina" uniqKey="Wittkampf L" first="Laura Christina" last="Wittkampf">Laura Christina Wittkampf</name><affiliation wicri:level="1"><nlm:affiliation>GGZ Drenthe, Mental Health Care, Assen, The Netherlands. Laura.Wittkampf@ggzdrenthe.nl</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>GGZ Drenthe, Mental Health Care, Assen</wicri:regionArea><wicri:noRegion>Assen</wicri:noRegion></affiliation></author><author><name sortKey="Smeets, Hugo M" sort="Smeets, Hugo M" uniqKey="Smeets H" first="Hugo M" last="Smeets">Hugo M. Smeets</name></author><author><name sortKey="Knol, Mirjam J" sort="Knol, Mirjam J" uniqKey="Knol M" first="Mirjam J" last="Knol">Mirjam J. Knol</name></author><author><name sortKey="Geerlings, Mirjam I" sort="Geerlings, Mirjam I" uniqKey="Geerlings M" first="Mirjam I" last="Geerlings">Mirjam I. Geerlings</name></author><author><name sortKey="Braam, Arjan W" sort="Braam, Arjan W" uniqKey="Braam A" first="Arjan W" last="Braam">Arjan W. Braam</name></author><author><name sortKey="De Wit, Niek J" sort="De Wit, Niek J" uniqKey="De Wit N" first="Niek J" last="De Wit">Niek J. De Wit</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:19701593</idno><idno type="pmid">19701593</idno><idno type="doi">10.1007/s00127-009-0123-4</idno><idno type="wicri:Area/PubMed/Corpus">000731</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000731</idno><idno type="wicri:Area/PubMed/Curation">000727</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000727</idno><idno type="wicri:Area/PubMed/Checkpoint">000715</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000715</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands.</title><author><name sortKey="Wittkampf, Laura Christina" sort="Wittkampf, Laura Christina" uniqKey="Wittkampf L" first="Laura Christina" last="Wittkampf">Laura Christina Wittkampf</name><affiliation wicri:level="1"><nlm:affiliation>GGZ Drenthe, Mental Health Care, Assen, The Netherlands. Laura.Wittkampf@ggzdrenthe.nl</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>GGZ Drenthe, Mental Health Care, Assen</wicri:regionArea><wicri:noRegion>Assen</wicri:noRegion></affiliation></author><author><name sortKey="Smeets, Hugo M" sort="Smeets, Hugo M" uniqKey="Smeets H" first="Hugo M" last="Smeets">Hugo M. Smeets</name></author><author><name sortKey="Knol, Mirjam J" sort="Knol, Mirjam J" uniqKey="Knol M" first="Mirjam J" last="Knol">Mirjam J. Knol</name></author><author><name sortKey="Geerlings, Mirjam I" sort="Geerlings, Mirjam I" uniqKey="Geerlings M" first="Mirjam I" last="Geerlings">Mirjam I. Geerlings</name></author><author><name sortKey="Braam, Arjan W" sort="Braam, Arjan W" uniqKey="Braam A" first="Arjan W" last="Braam">Arjan W. Braam</name></author><author><name sortKey="De Wit, Niek J" sort="De Wit, Niek J" uniqKey="De Wit N" first="Niek J" last="De Wit">Niek J. De Wit</name></author></analytic><series><title level="j">Social psychiatry and psychiatric epidemiology</title><idno type="eISSN">1433-9285</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Anti-Anxiety Agents (therapeutic use)</term><term>Antidepressive Agents (therapeutic use)</term><term>Antipsychotic Agents (therapeutic use)</term><term>Drug Prescriptions (statistics & numerical data)</term><term>Drug Utilization (trends)</term><term>Emigrants and Immigrants (MeSH)</term><term>Ethnic Groups (statistics & numerical data)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Mental Disorders (drug therapy)</term><term>Mental Disorders (epidemiology)</term><term>Mental Disorders (ethnology)</term><term>Middle Aged (MeSH)</term><term>Minority Groups (statistics & numerical data)</term><term>Morocco (ethnology)</term><term>Netherlands (ethnology)</term><term>Population Groups (statistics & numerical data)</term><term>Prevalence (MeSH)</term><term>Psychotropic Drugs (therapeutic use)</term><term>Social Class (MeSH)</term><term>Turkey (ethnology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Antidépresseurs (usage thérapeutique)</term><term>Anxiolytiques (usage thérapeutique)</term><term>Classe sociale (MeSH)</term><term>Ethnies (statistiques et données numériques)</term><term>Femelle (MeSH)</term><term>Groupes de population (statistiques et données numériques)</term><term>Humains (MeSH)</term><term>Maroc (ethnologie)</term><term>Minorités (statistiques et données numériques)</term><term>Mâle (MeSH)</term><term>Neuroleptiques (usage thérapeutique)</term><term>Ordonnances médicamenteuses (statistiques et données numériques)</term><term>Pays-Bas (ethnologie)</term><term>Prévalence (MeSH)</term><term>Psychoanaleptiques (usage thérapeutique)</term><term>Troubles mentaux (ethnologie)</term><term>Troubles mentaux (traitement médicamenteux)</term><term>Troubles mentaux (épidémiologie)</term><term>Turquie (ethnologie)</term><term>Utilisation médicament (tendances)</term><term>Émigrants et immigrants (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Anxiety Agents</term><term>Antidepressive Agents</term><term>Antipsychotic Agents</term><term>Psychotropic Drugs</term></keywords><keywords scheme="MESH" type="geographic" qualifier="ethnology" xml:lang="en"><term>Morocco</term><term>Netherlands</term><term>Turkey</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Mental Disorders</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Mental Disorders</term></keywords><keywords scheme="MESH" qualifier="ethnologie" xml:lang="fr"><term>Maroc</term><term>Pays-Bas</term><term>Troubles mentaux</term><term>Turquie</term></keywords><keywords scheme="MESH" qualifier="ethnology" xml:lang="en"><term>Mental Disorders</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Drug Prescriptions</term><term>Ethnic Groups</term><term>Minority Groups</term><term>Population Groups</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Ethnies</term><term>Groupes de population</term><term>Minorités</term><term>Ordonnances médicamenteuses</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Utilisation médicament</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Troubles mentaux</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Drug Utilization</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antidépresseurs</term><term>Anxiolytiques</term><term>Neuroleptiques</term><term>Psychoanaleptiques</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Troubles mentaux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Emigrants and Immigrants</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Social Class</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Classe sociale</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Prévalence</term><term>Émigrants et immigrants</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Maroc</term><term>Pays-Bas</term><term>Turquie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Psychotropic drug use in Europe and the USA has increased in the past 20 years. The rise in mental health-care use instigated a debate about possible differences in prevalence rates between different ethnic groups in the Netherlands, although the exact differences were unknown. The aim of this study was to determine whether these minority groups were more or less likely than the native population to receive psychotropic drugs.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>A descriptive population study was conducted using the Agis Health Database, containing demographic and health-care consumption data of approximately 1.5 million inhabitants of the Netherlands. Rates of prescriptions of psychotropic drugs from 2001 to 2006 and adjusted odds ratios for psychotropic drug prescriptions among native Dutch, Turkish and Moroccan ethnic groups were calculated. These data were analysed using logistic regression, after being adjusted for age, gender and socioeconomic status.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>The mean year prevalence of psychotropic drug prescriptions from 2001 to 2006 was 14.0%. Except for a decrease in anxiolytic drugs, the prescriptions of psychotropic drugs increased from 2001 to 2006. These trends were the same for all of the ethnic groups considered. Among both the Moroccan and Turkish populations, there was a higher risk of antidepressant and antipsychotic drug prescriptions, and a pronounced lower risk of ADHD medication and lithium prescriptions compared to the native population. Among the Turkish population, the risk of anxiolytic drug prescriptions was greater than in the native population.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Compared to the native population in the Netherlands, first- and second-generation Turkish and Moroccan immigrants had an increased risk of antidepressant and antipsychotic drug prescriptions and a decreased risk of ADHD medication and Lithium prescriptions. Further research is needed to clarify whether patients of different ethnic backgrounds with the same symptoms receive similar diagnosis and adequate treatment.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19701593</PMID><DateCompleted><Year>2010</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-9285</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>8</Issue><PubDate><Year>2010</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Social psychiatry and psychiatric epidemiology</Title><ISOAbbreviation>Soc Psychiatry Psychiatr Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands.</ArticleTitle><Pagination><MedlinePgn>819-26</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00127-009-0123-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Psychotropic drug use in Europe and the USA has increased in the past 20 years. The rise in mental health-care use instigated a debate about possible differences in prevalence rates between different ethnic groups in the Netherlands, although the exact differences were unknown. The aim of this study was to determine whether these minority groups were more or less likely than the native population to receive psychotropic drugs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A descriptive population study was conducted using the Agis Health Database, containing demographic and health-care consumption data of approximately 1.5 million inhabitants of the Netherlands. Rates of prescriptions of psychotropic drugs from 2001 to 2006 and adjusted odds ratios for psychotropic drug prescriptions among native Dutch, Turkish and Moroccan ethnic groups were calculated. These data were analysed using logistic regression, after being adjusted for age, gender and socioeconomic status.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean year prevalence of psychotropic drug prescriptions from 2001 to 2006 was 14.0%. Except for a decrease in anxiolytic drugs, the prescriptions of psychotropic drugs increased from 2001 to 2006. These trends were the same for all of the ethnic groups considered. Among both the Moroccan and Turkish populations, there was a higher risk of antidepressant and antipsychotic drug prescriptions, and a pronounced lower risk of ADHD medication and lithium prescriptions compared to the native population. Among the Turkish population, the risk of anxiolytic drug prescriptions was greater than in the native population.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Compared to the native population in the Netherlands, first- and second-generation Turkish and Moroccan immigrants had an increased risk of antidepressant and antipsychotic drug prescriptions and a decreased risk of ADHD medication and Lithium prescriptions. Further research is needed to clarify whether patients of different ethnic backgrounds with the same symptoms receive similar diagnosis and adequate treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wittkampf</LastName><ForeName>Laura Christina</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>GGZ Drenthe, Mental Health Care, Assen, The Netherlands. Laura.Wittkampf@ggzdrenthe.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smeets</LastName><ForeName>Hugo M</ForeName><Initials>HM</Initials></Author><Author ValidYN="Y"><LastName>Knol</LastName><ForeName>Mirjam J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Geerlings</LastName><ForeName>Mirjam I</ForeName><Initials>MI</Initials></Author><Author ValidYN="Y"><LastName>Braam</LastName><ForeName>Arjan W</ForeName><Initials>AW</Initials></Author><Author ValidYN="Y"><LastName>De Wit</LastName><ForeName>Niek J</ForeName><Initials>NJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Soc Psychiatry Psychiatr Epidemiol</MedlineTA><NlmUniqueID>8804358</NlmUniqueID><ISSNLinking>0933-7954</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014151">Anti-Anxiety Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014151" MajorTopicYN="N">Anti-Anxiety Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054242" MajorTopicYN="N">Emigrants and Immigrants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnic Groups</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008913" MajorTopicYN="N">Minority Groups</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009018" MajorTopicYN="N" Type="Geographic">Morocco</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044382" MajorTopicYN="N">Population Groups</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012923" MajorTopicYN="N">Social Class</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>09</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>08</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>8</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>8</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19701593</ArticleId><ArticleId IdType="doi">10.1007/s00127-009-0123-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Affect Disord. 2004 Nov 15;83(1):33-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15546643</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2006 Sep;86(1-3):189-93</Citation><ArticleIdList><ArticleId IdType="pubmed">16839747</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2007 Jan;97(1-3):229-39</Citation><ArticleIdList><ArticleId IdType="pubmed">16901547</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2002 Jun;105(6):440-3</Citation><ArticleIdList><ArticleId IdType="pubmed">12059848</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pharmacol Ther. 2007 Jan;45(1):23-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17256447</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Psychiatry Psychiatr Epidemiol. 2004 Nov;39(11):883-92</Citation><ArticleIdList><ArticleId IdType="pubmed">15549240</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Child Adolesc Psychiatry. 2006 Oct;15(7):418-26</Citation><ArticleIdList><ArticleId IdType="pubmed">16685474</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijdschr Gerontol Geriatr. 2005 Nov;36(5):194-202</Citation><ArticleIdList><ArticleId IdType="pubmed">16350528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ned Tijdschr Geneeskd. 1996 Feb 17;140(7):368-71</Citation><ArticleIdList><ArticleId IdType="pubmed">8628423</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2001 Apr;178:367-72</Citation><ArticleIdList><ArticleId IdType="pubmed">11282817</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2007 May;16(5):560-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17286304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ned Tijdschr Geneeskd. 1994 Feb 12;138(7):345-50</Citation><ArticleIdList><ArticleId IdType="pubmed">8121523</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1988 Aug;18(3):643-57</Citation><ArticleIdList><ArticleId IdType="pubmed">3263659</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Psychiatry Psychiatr Epidemiol. 2009 Mar;44(3):208-16</Citation><ArticleIdList><ArticleId IdType="pubmed">18787746</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):476-83</Citation><ArticleIdList><ArticleId IdType="pubmed">16601653</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand Suppl. 2004;(420):55-64</Citation><ArticleIdList><ArticleId IdType="pubmed">15128388</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Psychiatry Psychiatr Epidemiol. 1994 Apr;29(2):71-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8009322</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Psychiatry Psychiatr Epidemiol. 2003 Oct;38(10):547-50</Citation><ArticleIdList><ArticleId IdType="pubmed">14564382</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2001 Apr;16(3):162-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11353594</ArticleId></ArticleIdList></Reference><Reference><Citation>J Epidemiol Community Health. 2001 Oct;55(10):701-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11553652</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2002 Dec;17(8):443-50</Citation><ArticleIdList><ArticleId IdType="pubmed">12504260</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2005 Aug;187:101-2</Citation><ArticleIdList><ArticleId IdType="pubmed">16055818</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country></list><tree><noCountry><name sortKey="Braam, Arjan W" sort="Braam, Arjan W" uniqKey="Braam A" first="Arjan W" last="Braam">Arjan W. Braam</name><name sortKey="De Wit, Niek J" sort="De Wit, Niek J" uniqKey="De Wit N" first="Niek J" last="De Wit">Niek J. De Wit</name><name sortKey="Geerlings, Mirjam I" sort="Geerlings, Mirjam I" uniqKey="Geerlings M" first="Mirjam I" last="Geerlings">Mirjam I. Geerlings</name><name sortKey="Knol, Mirjam J" sort="Knol, Mirjam J" uniqKey="Knol M" first="Mirjam J" last="Knol">Mirjam J. Knol</name><name sortKey="Smeets, Hugo M" sort="Smeets, Hugo M" uniqKey="Smeets H" first="Hugo M" last="Smeets">Hugo M. Smeets</name></noCountry><country name="Pays-Bas"><noRegion><name sortKey="Wittkampf, Laura Christina" sort="Wittkampf, Laura Christina" uniqKey="Wittkampf L" first="Laura Christina" last="Wittkampf">Laura Christina Wittkampf</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/MaghrebDataLibMedV2/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000715 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000715 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= MaghrebDataLibMedV2
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:19701593
|texte= Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19701593" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a MaghrebDataLibMedV2
| This area was generated with Dilib version V0.6.38. |  |